The Former Director Of The NIH Shared His Prostate Cancer Journey. Use His Story To Reduce Your Risk Of Dying Of This Disease. [Forbes]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Forbes
Why did he share this personal news? Because he wants to share lifesaving information about prostate cancer , the most common cancer and the #2 cause of cancer death among men in the United States. Dr. Collins served as the director of the National Institutes of Health from 2009 to 2021. But genetics geeks, like myself, remember him as the director of the National Human Genome Research Institute from 1993 to 2008, during which time the human genome was sequenced . This accomplishment was one of the greatest medical breakthroughs of our generation. And its promise is still unfolding twenty years later, with new tests, discoveries, and precision medicines being developed based on genomic technologies. There is an opportunity for some men who discover their prostate cancer at an early stage to consider ‘active surveillance' instead of more radical, traditional approaches. For some men with an inherited form of prostate cancer, such as those with a BRCA2 mutation, the cancer may be mo
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024GlobeNewswire
- Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards [Yahoo! Finance]Yahoo! Finance
- Nearly Half of Americans Say They've Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor [Yahoo! Finance]Yahoo! Finance
- Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health MonitorGlobeNewswire
- New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen [Yahoo! Finance]Yahoo! Finance
MYGN
Earnings
- 2/27/24 - Beat
MYGN
Sec Filings
- 5/1/24 - Form SC
- 4/25/24 - Form SC
- 4/17/24 - Form ARS
- MYGN's page on the SEC website